FT : Boeing takeover of Embraer jets business in jeopardy

Boeing takeover of Embraer jets business in jeopardy
US company considers walking away as two sides haggle over conditions with hours to deadline

Boeing’s plan to acquire the regional jet business of Brazil’s Embraer hung in the balance on Friday as the two sides haggled over conditions attached to the multibillion-dollar tie-up just hours ahead of a deadline giving each the right to walk away.

The US aircraft maker, which is haemorrhaging billions of dollars of cash as a result of the year-long grounding of the 737 Max and the global aviation crisis, is weighing whether to abandon the deal.

People close to the matter said no decision would be taken until the midnight deadline had passed, but an announcement could come as soon as this weekend.

The deadline was agreed in a contract signed in January, which set a timetable for both sides to meet certain conditions.

If Boeing decides to walk away rather than extend the agreement, it is expected to cite Embraer’s failure to meet certain terms as the reason for abandoning the deal, the people said. EU approval is also still outstanding.

Analysts said Boeing had a big incentive to walk away. “It’s a liquidity question,” said Bank of America Merrill Lynch analyst Ron Epstein. “Is Boeing in a position to spend $4.2bn on an acquisition given what’s going on in the broader commercial aviation market?”

FT : Mirae misses payment on $5.8bn Anbang hotel deal

Mirae misses payment on $5.8bn Anbang hotel deal
Korean asset manager had promised to buy a chain of luxury US hotels sold off by the distressed Chinese insurer

The Korean asset manager that had promised to buy a chain of luxury US hotels sold off by distressed Chinese insurer Anbang has failed to make a payment due on April 17, raising questions about whether the $5.8bn deal will proceed as planned.

Mirae Asset Management won the 15-site Strategic Hotels portfolio in an auction last year, seeing off bids from a host of deep-pocketed investors including Blackstone, which had sold the chain to Anbang, Brookfield, SoftBank-backed Fortress and Government Investment Corp of Singapore.

Mirae said the deal was still ongoing and that it was in talks with Anbang. “We are still negotiating the deal [with Anbang] and continue to communicate with them,” said a company spokesman, who denied Mirae was in technical default, adding there had been no agreed deadline for the payment.

The company was “still tapping multiple US financial institutions for loans for the deal although market conditions have become tougher due to the virus outbreak”, said one person close to Mirae. “Its affiliates as well as banks and financial companies will also throw money into the deal, so even if one or two banks will not lend money, this does not mean a deal collapse.”

But a person familiar with Anbang’s position said: “Everyone knew Mirae had paid way too much.”

“Nobody will lend money for such a deal when the hotels have almost zero occupancy. Anbang has sent notices to the Korean side but there has been no response in writing.”

The transaction is the latest in a number of high profile mergers that have been thrown into doubt by the coronavirus pandemic.

If the deal falls through, Mirae stands to lose its $600m deposit and could face lawsuits. The terms of its purchase agreement do not specify a pandemic as a material adverse clause that would give it flexibility.

Anbang, meanwhile, is still paying off the money it borrowed to buy the hotels from Blackstone in 2016. As of 2018, it has been under government control, with the Chinese Banking and Insurance Regulatory Commission calling the shots, and it is not clear if it will be given additional funds to help it refinance those debts if required.

The news comes as the market for financing real estate transactions for hotels and retail property is in total disarray, with many retailers and hotels in violation of the terms of their loans. “Many hotels can’t pay off their mortgages. It will be years before Anbang can get a decent price for Strategic,” said one person with knowledge of the market.

The Strategic Hotels portfolio includes the Westin St Francis in San Francisco, the JW Marriott Essex House in New York, the Fairmont Scottsdale Princess, and several Ritz-Carlton and Four Seasons hotels.

The refurbishment of another Anbang-owned asset, the Waldorf Astoria in New York, has come to a halt because of the pandemic.

The 1,413-room hotel was being converted into one with 375 rooms, plus 375 luxury apartments for sale.

But the sales office is now shuttered and only a handful of contracts have been signed for the apartments.

Anbang spent more than $1.95bn buying the building in 2014 and a further $1bn so far on reconstruction.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • OZK -6.8%, SIVB -6.4%, LLNW -6.2%, INTC -5%, FE -3.1%, EHTH -2.6%, ABCB -1.2%, LOGM -0.8%, POR -0.6%

Other news:

  • GOOG -0.9% (CNBC report that Google to cut marketing budgets by as much as half)
  • RE -0.5% (announces Q1 impact from COVID-19)

Analyst comments:

  • TEX -4.7% (downgraded to Neutral from Outperform at Credit Suisse)
  • SPLK -2.1% (downgraded to Market Perform from Outperform at Cowen)
  • WDAY -1.9% (downgraded to Market Perform from Outperform at Cowen)
  • IMAX -1.9% (downgraded to Neutral from Outperform at Wedbush)
  • ILMN -1% (downgraded to Neutral from Buy at Citigroup)
  • EPAM -0.9% (downgraded to Neutral from Positive at Susquehanna)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:

  • WWE +13.4%, PBCT +10%, TPH +7.5%, EW +7.4%, ALV +7.4%, VCRA +5.6%, B +5.1%, VICR +4%, MMSI +2.8%, AXP +2.8%, ASB +2.2%, BOOM +1.9%, VRSN +1.8%, TRTN +1.6%, COF +1.5%, RHI +1.1%, VZ +1.1%, SNY +0.8%

Other news:

  • MESO +82.2% (reports 83% survival in COVID-19 patients with moderate/severe acute respiratory distress syndrome treated in New York with Cell Therapy Remestemcel-L)
  • CHK +16.2% (adopts shareholder rights plan)
  • PSTI +15.8% (secures EUR 50 mln non-dilutive financing from the european investment bank to support its COVID-19 project and phase 3 studies)
  • EBS +7.8% (Emergent BioSolutions agrees to be U.S. manufacturing partner for Johnson & Johnson's (JNJ) lead vaccine candidate for COVID-19)
  • DVAX +4.1% (indicated higher after confirming will report first quarter 2020 financial results on Thursday, May 7, 2020, after the U.S. financial markets close)
  • ZM +3.8% (to join the NASDAQ-100 Index beginning April 30)
  • MR +1.2% (provides preliminary Q1 production update)
  • LLY +1% (Eli Lilly and Innovent reports NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA)

Analyst comments:

  • OII +3.3% (upgraded to Buy from Neutral at Citigroup)
  • EXPE +2.6% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
  • EBAY +2.1% (upgraded to Buy from Hold at Stifel)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • WWE +12.1%, PBCT +10.8%, CHK +8.9%, TPH +7.5%, ALV +6.4%, VCRA +5.7%, B +5.1%, EW +4.8%, VICR +4%, MMSI +2.8%, ASB +2.2%, BOOM +1.9%, MR +1.2%, RHI +1.1%, SPR +0.7%, SEIC +0.7%
  • Gapping down:
    • LLNW -6.9%, OZK -6.8%, SIVB -6.4%, INTC -4.3%, FE -3.1%, EHTH -1.9%, SNY -1.4%, GRUB -1.3%, ABCB -1.2%, GOOG -1.1%, COF -0.8%, LOGM -0.8%

>>> Stoxx 600 Pre-Market Indications

  • Uniper (UN01 TH) +4.2%
    • Uniper 1Q Prelim. Adj Ebit About EU650 Million; Backs Forecast
  • Carnival Plc (POH1 TH) +1.6%
  • Sanofi (SNW TH) +0.5%
    • Sanofi Gets Covid-19 Sales Burst as Lockdowns Fueled Stocking Up
  • Hannover Re (HNR1 TH) -2.4%
  • Fresenius SE (FRE TH) -2.5%
  • Bechtle (BC8 TH) -2.5%
  • Daimler (DAI TH) -2.5%
  • Lufthansa (LHA TH) -2.6%
    • Lufthansa Warns of Cash Crunch After Oil Crush Deepens Pain (1)
  • Nemetschek (NEM TH) -3.1%
  • Deutsche Bank (DBK TH) -3.2%
  • TUI (TUI1 TH) -3.4%
  • Commerzbank (CBK TH) -3.6%
    • S&PGR Downgrades​​​​​​​ Commerzbank AG To ‘BBB+’; Outlook Negative
  • ThyssenKrupp (TKA TH) -3.7%